MedTrace Logo

Risk Stratification in Children and Adolescents With Primary Cardiomyopathy

NCT03572569 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-06-28

No results posted yet for this study

Summary

RIKADA is a prospective study performing systematic family screening including clinical and genetic testing in pediatric patients with primary cardiomyopathy and their first-degree relatives with the aim to facilitate risk stratification.

Conditions

  • Primary Cardiomyopathy
  • Dilated Cardiomyopathy
  • Hypertrophic Cardiomyopathy
  • Left Ventricular Noncompaction
  • Restrictive Cardiomyopathy
  • Arrhythmogenic Right Ventricular Cardiomyopathy

Sponsors & Collaborators

  • Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

    collaborator OTHER

  • German Heart Institute

    lead OTHER

Principal Investigators

  • Felix Berger, MD · German Heart Institute

  • Sabine Klaassen, MD · Charite University, Berlin, Germany

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03572569 on ClinicalTrials.gov